Several position papers that cover non-pharmacological management, discharge planning, and standards for delivering HF care.Īppropriate self-management by patients with HF plays an important role in the prevention of HF decompensation and improvement of survival and quality of life (QOL). To reduce mortality and rehospitalization rate, it is widely recognized that, in addition to optimizing medical and device therapies for HF, attention should also be given to how HF care is delivered. Although some progress has been made in reducing mortality in patients with HF, rates of rehospitalization continue to rise and approach 40–50% within 1 year after discharge. Usually, as studies only include diagnosed HF cases, the true prevalence is likely to be higher. The prevalence of HF among approximately 1–2% of the adult population in developed countries, rising to ≧10% among those over 70 years of age and the most common reason for hospitalization in older adults.
HF is the quintessential cardiovascular syndrome of aging that results from age-related cardiovascular conditions and age-associated changes in cardiovascular structure and function.
0 kommentar(er)
